Notably, despite the limited correlation between methylomes of different tissues, the identification of conserved epigenetic signatures—such as changes in NRF1, HLA-DQ2, and SREBF1—offers promising opportunities for the development of integrated diagnostic strategies that combine both tissue-specific and systemic epigenetic markers of obesity. This evidence concerns the gene SREBF1 and Obesity.